TY - JOUR
T1 - Association Between Multi-frequency Phase Angle and Survival in Patients With Advanced Cancer
AU - Hui, David
AU - Dev, Rony
AU - Pimental, Lindsay
AU - Park, Minjeong
AU - Cerana, Maria A.
AU - Liu, Diane
AU - Bruera, Eduardo
N1 - Publisher Copyright:
© 2016 American Academy of Hospice and Palliative Medicine
PY - 2017/3/1
Y1 - 2017/3/1
N2 - Context The ability to predict survival accurately has implications in clinical decision making. Objectives We determined the association of phase angle obtained from multi-frequency bioelectric impedance analysis with overall survival in patients with advanced cancer. Methods We included consecutive patients with advanced cancer who had an outpatient palliative care consultation. Multi-frequency bioelectric impedance analysis assessed phase angle at three different frequencies (5/50/250 kHz) on each hemibody (right/left). Survival analysis was conducted using the Kaplan-Meier method, log-rank test, and multivariate Cox regression analysis. Results Among 366 patients, the median overall survival was 250 days (95% confidence interval 191–303 days). The mean phase angle for 5, 50, and 250 kHz were 2.2°, 4.4°, and 4.2° on the right and 2.0°, 4.2° and 4.1° on the left, respectively. For all six phase angles, a lower value was significantly associated with a poorer overall survival (P < 0.001). After adjusting for cancer type, performance status, weight loss, and inflammatory markers, phase angle remained independently associated with overall survival (hazard ratio 0.85 per degree increase, 95% confidence interval 0.72–0.99; P = 0.048). Conclusion Phase angle represents a novel objective prognostic factor in outpatient palliative cancer care setting, regardless of frequency and body sides.
AB - Context The ability to predict survival accurately has implications in clinical decision making. Objectives We determined the association of phase angle obtained from multi-frequency bioelectric impedance analysis with overall survival in patients with advanced cancer. Methods We included consecutive patients with advanced cancer who had an outpatient palliative care consultation. Multi-frequency bioelectric impedance analysis assessed phase angle at three different frequencies (5/50/250 kHz) on each hemibody (right/left). Survival analysis was conducted using the Kaplan-Meier method, log-rank test, and multivariate Cox regression analysis. Results Among 366 patients, the median overall survival was 250 days (95% confidence interval 191–303 days). The mean phase angle for 5, 50, and 250 kHz were 2.2°, 4.4°, and 4.2° on the right and 2.0°, 4.2° and 4.1° on the left, respectively. For all six phase angles, a lower value was significantly associated with a poorer overall survival (P < 0.001). After adjusting for cancer type, performance status, weight loss, and inflammatory markers, phase angle remained independently associated with overall survival (hazard ratio 0.85 per degree increase, 95% confidence interval 0.72–0.99; P = 0.048). Conclusion Phase angle represents a novel objective prognostic factor in outpatient palliative cancer care setting, regardless of frequency and body sides.
KW - Electric impedance
KW - forecasting
KW - neoplasms
KW - palliative care
KW - prognosis
KW - survival
UR - http://www.scopus.com/inward/record.url?scp=85011628806&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85011628806&partnerID=8YFLogxK
U2 - 10.1016/j.jpainsymman.2016.09.016
DO - 10.1016/j.jpainsymman.2016.09.016
M3 - Article
C2 - 28042079
AN - SCOPUS:85011628806
SN - 0885-3924
VL - 53
SP - 571
EP - 577
JO - Journal of pain and symptom management
JF - Journal of pain and symptom management
IS - 3
ER -